ArticleJournal of blood medicine2026
Clinical and Genetic Pattern of β-Thalassemia Major in East Java, Indonesia.
Article in Journal of blood medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Beta thalassemia major is the most common monogenic mutation disorder in Indonesia, with steadily increasing frequency. However, there are limited studies regarding genetic distribution and its relationship with the patient's clinical manifestation. This study aimed to identify the genetic mutation frequency and its association with the clinical phenotype pattern among β-thalassemia major patients in East Java, Indonesia. Methods: In this observational study, we include subjects who have diagnosed with β-thalassemia previously through Hb electrophoresis. Demographic distribution with several ethnicities of Javanese, Sundanese, Chinese, Maduranese, and Batak was recorded. From each subject, a total of 6 mL of blood sample was collected and divided into two ethylene diamine tetraacetic acid (EDTA) tubes for CBC and DNA extraction. DNA samples were analyzed by PCR and followed by Sanger sequencing. Results: A total of 91 subjects were included in this study, with a median age of 22.25 ± 7.56 years old; consisting of 52 females and 39 males, with Javanese as the most common ethnicity. There are 22 types of mutation were identified through Sanger sequencing. The most common mutation was IVS-1-5/CD 26 and the CD 35/CD 26 observed in 36 (39.5%) and 19 (20.8%), respectively. While 9 subjects (9.8%) had no mutation detected. Several clinical phenotypes, including iron overload, short stature, severe anemia, and splenomegaly, were most prevalent among the two most common genetic mutations. Conclusion: There is variability in clinical phenotype in β-thalassemia observed in several types of genotype mutations. Among all the mutations found in East Java, the genotypes IVS-1-5/CD 26 and CD 35/CD 26 were the two most frequent genotypes. Those genotypes are linear with the severity of the phenotype in β-thalassemia, such as severe anemia, iron overload, short stature, and splenomegaly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.